Family physicians have until May 15 to review and, if needed, dispute data reported to CMS about their interactions with pharmaceutical and medical device manufacturers in 2022.
Any data not disputed by the May 15 deadline will be published June 30 as part of the Open Payments™ Program, a national transparency initiative that collects and publishes information about financial relationships between the medical products industry and physicians and certain other health care entities.
Learn more: Review Your Open Payments Data for 2022 by May 15